FourThought Financial Partners, LLC

Position in LLY — ELI LILLY & Co

CIK 1956790 VENICE, FL

Position in LLY

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$7,075,438

+$1,946,801 QoQ

Shares Held

5,899

+5.8% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.65%

of 13F equity value

Holder Rank

#1,464

of 4,605 holders

Holding Since

Dec 2022

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

FourThought Financial Partners, LLC holds $48,924,367 across 10 Drug Manufacturers - General names. LLY ranks #3 (14.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AZN	Astrazeneca PLC	80,917	$15,343,481
2	AMGN	Amgen Inc	32,361	$11,718,565
3	LLY	ELI LILLY & Co This page	5,899	$7,075,438
4	NVO	Novo Nordisk A S	102,109	$4,895,105
5	ABBV	AbbVie Inc.	17,032	$4,285,932
6	JNJ	Johnson & Johnson	14,967	$3,801,168
7	MRK	Merck & Co., Inc.	4,550	$584,675
8	GILD	Gilead Sciences, Inc.	3,418	$431,830

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$7,075,438	5,899	+5.8%	Shares	Sole	2026-08-12
2026-03-31	$5,128,637	5,576	+2.3%	Shares	Sole	2026-05-07
2025-12-31	$5,859,155	5,452	+0.3%	Shares	Sole	2026-02-06
2025-09-30	$4,145,379	5,433	+71.9%	Shares	Sole	2025-11-13
2025-06-30	$2,463,314	3,160	+36.1%	Shares	Sole	2025-08-12
2025-03-31	$1,916,937	2,321	+1.0%	Shares	Sole	2025-05-07
2024-12-31	$1,773,284	2,297	+3.9%	Shares	Sole	2025-02-04
2024-03-31	$1,720,069	2,211	-23.6%	Shares	Sole	2024-05-14
2023-12-31	$1,686,387	2,893	+0.1%	Shares	Sole	2024-02-13
2023-09-30	$1,551,768	2,889	+0.3%	Shares	Sole	2023-11-13
2023-06-30	$1,350,193	2,879	-4.6%	Shares	Sole	2023-08-11
2023-03-31	$1,036,441	3,018	+18.2%	Shares	Sole	2023-05-04
2022-12-31	$933,989	2,553	—	Shares	Sole	2023-02-07
No filing history on record for this holder in this stock.